The global CranioMaxillofacial implants market is expected to reach USD 2.49 Billion by 2021 from USD 1.79 Billion in 2016 at a CAGR of 6.9% from 2016 to 2021. The global market is broadly classified into type, application site, material of construction, property and regions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43426581

Based on type, the craniomaxillofacial implants market is segmented into mid face implants, mandibular orthognathic implants, cranial/neuro implants, bone graft substitutes, distraction systems, total TMJ replacement systems, cranial flap fixation systems, thoracic fixation systems, and dural repair products. Mid-face implants segment is poised to witness the highest growth rate in the market. The growth of this market segment is attributed to the increasing number of road accident and trauma cases worldwide.

Based on material of construction, the craniomaxillofacial implants market is segmented into titanium, other metals, and alloys; polymers/biomaterials; and calcium phosphate ceramics. Polymers/biomaterials segment is expected to witness highest growth rate in the market. This growth is attributed due to the growing preference for polymers/biomaterials as a result of their resorbable properties among the clinicians across the globe.

The craniomaxillofacial implants market, by application site, is segmented into external fixators and internal fixators The external fixators segment is expected witness the highest growth rate in the market. The growth of this segment is attributed to extensive usage of external fixators in the neurosurgery.
The craniomaxillofacial implants market, by property, is segmented into non-resorbable fixators and resorbabale fixators. Resorbable fixators segment is expected to witness the highest growth rate in the craniomaxillofacial implants. This growth is mainly driven by advantages of resorbable fixators such as Shorter healing time and no need for the follow up surgery to remove the fixator.

In the coming five years, growth in the Craniomaxillofacial implants market is likely to be centered in Asia. Growth in this region can be attributed to the increasing number of road accident cases and resultant injuries, trauma cases, growing number of hospitals, and rising number of newborns with facial deformities in the Asian region is further driving the growth of this market.

The key players in the craniomaxillofacial implants market are Stryker (U.S.), KLS Martin (U.S.), Depuy Synthes (U.S.)., Zimmer Biomet (U.S.), Medtronic (Ireland), Integra Lifesciences (U.S.), OsteoMed (U.S.), Medartis AG (Switzerland), Matrix Surgical USA (U.S.), and Calavera (U.S.)